In addition, the validation of the WTAP-YTHDF1-GLUT3 axis has thus far been limited to human NASH samples available in public datasets, and has not yet been conducted within our own cohort. Here, SLC2A3 is linked to metabolic dysfunction-associated steatohepatitis.